Prices are checked against each store and labelled with when.
It checks today's price at every store, compares the alternatives and answers in about a minute.
Compounded tirzepatide is a prescription-only injectable made by a compounding pharmacy, not the brand-name product. It is a dual GIP and GLP-1 receptor agonist, the same mechanism as Zepbound and Mounjaro, and is used for appetite control and weight management under provider supervision. It suits people who want the tirzepatide mechanism without going through insurance, with dosing set by a clinician. The trade-off against brand tirzepatide is that compounded versions are not FDA-approved as finished products, so potency and purity depend on the pharmacy.
In stockReturn policy
Compounded tirzepatide is a medically guided treatment for appetite control and weight management. It acts on GLP-1 and GIP receptors and may help reduce appetite and increase feelings of fullness. It is meant to be used as part of a medically supervised treatment plan.
It is injected subcutaneously once a week, with or without food. Dosing follows the instructions from the prescribing provider. Higher-dose treatment may require documentation of recent treatment and is subject to provider approval.
